Nathanael R. Fillmore
Topics / Case-Control Study
Topic

Case-Control Study

Fillmore has employed case-control methodologies to identify critical determinants of disease severity and oncologic risk. His research has demonstrated that patients with hematologic cancers are at an increased risk for severe COVID-19, particularly those receiving immunosuppressive therapies. Additionally, his work indicates that a history of autoimmune or immune-mediated conditions is associated with a significantly lower risk of developing uveal melanoma.

U.S. Veterans and VA Data 2 Logistic Regression 2 Risk Factors 2 Uveal Melanoma 1 Cutaneous Melanoma 1 Autoimmune Diseases 1 Observational Study 1 Electronic Health Records 1 COVID-19 1 Severe COVID-19 1 Hematologic Malignancies 1 Vaccination 1

Publications (2)

2026

Risk and protective factors for uveal melanoma: Evidence for a protective role of autoimmune and immune-mediated conditions.

Charles Lu†, Debby Cheng†, Andrew Mu, Olivia Burke, Lirit Fuksman, Priya Katyal, Sara Khattab, Nga Nguyen, Emma Beagles, Crystal Chang, Suzanne Xu, Jonathan C. Hwang, Linden Huhmann, Nicholas Starink, Martin A. Weinstock, Maryam M. Asgari, Marc S. Hurlbert, John M. Gaziano, Nathanael R. Fillmore, Rebecca I. Hartman, Yevgeniy R. Semenov† Equal first authorship

Journal of the American Academy of Dermatology95(1), 211-214
U.S. Veterans and VA Data Case-Control Study Uveal Melanoma Cutaneous Melanoma Logistic Regression